PD-1/PD-L1 inhibitors
US12269812B2 · kind B2 · utility
0Cited by
29References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 8, 2020 |
| Grant date | Apr 8, 2025 |
| Priority date | — |
| Expiry date | Jul 8, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds and methods of using said compounds singly or in combination with additional agents and compositions of said compounds for the treatment of cancer are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.